SPRC - Why SciSparc Ltd Stock Is Blasting Higher | Benzinga
SciSparc Ltd. (NASDAQ: SPRC) shares are trading higher Friday after the company announced it has launched a clinical trial of its combination of cannabidiol (CBD) and SciSparc's proprietary Palmitoylethanolamide, to treat the symptoms of autism spectrum disorder (ASD).
The Details:
SciSparc said that the trial will enroll 60 participants between the ages of 5-18 years old and will measure how ...